ACUTA CAPITAL PARTNERS, LLC - PERNIX THERAPEUTICS HLDGS IN ownership

PERNIX THERAPEUTICS HLDGS IN's ticker is PTX and the CUSIP is 71426V108. A total of 47 filers reported holding PERNIX THERAPEUTICS HLDGS IN in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
ACUTA CAPITAL PARTNERS, LLC ownership history of PERNIX THERAPEUTICS HLDGS IN
ValueSharesWeighting
Q3 2016$46,000
+64.3%
73,500
+17.0%
0.02%
+30.8%
Q2 2016$28,000
-97.8%
62,800
-85.5%
0.01%
-97.9%
Q4 2015$1,281,000
-63.4%
434,300
-60.8%
0.61%
-69.8%
Q3 2015$3,504,000
-6.4%
1,108,719
+216.8%
2.03%
-35.6%
Q1 2015$3,742,000
-34.0%
350,000
-42.1%
3.15%
-17.8%
Q4 2014$5,672,000604,0753.83%
Other shareholders
PERNIX THERAPEUTICS HLDGS IN shareholders Q3 2016
NameSharesValueWeighting ↓
Sageview Capital 2,223,339$5,603,0001.59%
Orbimed Advisors 2,320,800$5,848,0000.09%
F&C Asset Management plc 1,854,808$4,665,0000.06%
SPHERA FUNDS MANAGEMENT LTD. 56,500$142,0000.04%
Yakira Capital Management, Inc. 11,957$30,0000.03%
Spectrum Management Group, LLC 10,000$25,0000.02%
Weiss Multi-Strategy Advisers LLC 41,152$104,0000.00%
WOLVERINE ASSET MANAGEMENT LLC 30,000$75,0000.00%
PUTNAM INVESTMENTS LLC 129,762$327,0000.00%
Partnervest Advisory Services LLC 220$1,0000.00%
View complete list of PERNIX THERAPEUTICS HLDGS IN shareholders